3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Keratosis, Actinic
3
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Pelvic Neoplasms
1
Pain
1
Oropharyngeal Neoplasms
1
Neoplasms, Cystic, Mucinous, and Serous
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Brain Neoplasms
1
Agnosia
1
Interventions
Cisplatin
17
pembrolizumab
12
Radiotherapy
11
Nivolumab
7
Cetuximab
6
Paclitaxel
5
fludarabine
4
aldesleukin
4
Radiation
4
Interleukin-2
4
Docetaxel
4
Cyclophosphamide
4
olaparib
3
fludarabine phosphate
3
Carboplatin
3
talimogene laherparepvec
2
atezolizumab
2
Taxes
2
Sorafenib
2
Fluorouracil
2
Erlotinib Hydrochloride
2
Drug Therapy
2
Capecitabine
2
Bortezomib
2
130-nm albumin-bound paclitaxel
2
vandetanib
1
tozuleristide
1
tilsotolimod
1
testosterone enanthate
1
temoporfin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Carcinoma, Squamous Cell
×
Lidocaine
×
Clear all
NCT06747390
2026-05-12
856397
Abramson Cancer Center at Penn Medicine
Phase 1
Recruiting
30 enrolled